The U.S. needs to revitalize research on the health effects of low-dose radiation; European researchers seek greater stake in drug development

Relatively little is understood about the effects of low doses of radiation experienced by millions of Americans. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        Opinion: The U.S. needs to revitalize research on the health effects of low-dose radiation By Joe Gray and Lindsay Morton and Gayle Woloschak Adobe Research on the health effects of low-dose radiation has been de-prioritized in recent years. The U.S. needs to revitalize it. Read More STAT+: European researchers seek greater stake in drug development in bid to improve access By Jessica Davis Plüss Pierre Crom/Getty Images The effort has had some success with medicines destined for low-income countries, but has faced hurdles in Europe itself. Read More Sponsor content by Astellas How established and emerging biomarkers are changing the gastric cancer landscape In the United States, approximately 6% of patients with metastatic gastric cancer survive 5 years post diagnosis. Emerging research is revealing potential opportunities to advance care through the exploration of novel and established biomarkers, working to identify new patient subsets and inform clinical decisions. As clinicians work to better understand the unique profile of gastric cancer, visit GastricCancerBiomarkers.com to find out how biomarkers are changing the landscape. STAT+: Verily co-founder lays out vision for how real-world data can transform health care By Jonathan Wosen Jason Henry for STAT STAT sat down with Jessica Mega, Verily’s co-founder and chief medical and scientific officer, to learn more about the issue. Read More STAT+: Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy By Ed Silverman Kris Connor/Getty Images for A+E Networks Medicare could have saved up to $3.6 billion in 2020 – or 37% of the $9.6 billion spent on 77 of 89 different prescription medicines. Read More Tuesday, June 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser